Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:3988
SEHK:3988Banks

Where Does Bank of China Stand After a 23.8% Stock Price Surge in 2025?

If you’re eyeing Bank of China right now, you’re not alone. With sizable moves in its share price lately and some headlines stirring up investor sentiment, it’s a stock worth a closer look. Over the past week, Bank of China’s shares have crept up 2.6%, contributing to a sturdy 23.8% climb over the last year and an impressive 163.2% surge in the past five years. Those kinds of returns don’t just happen by accident. Clearly, something is shifting in how investors perceive the risks and...
NasdaqCM:SEV
NasdaqCM:SEVAuto

Evaluating Aptera Motors’s Valuation Following Public Benefit Shift and Board Expansion

Aptera Motors has officially transitioned to a Public Benefit Corporation. This move ties its governance to sustainability goals in solar electric vehicle development. The company also strengthened its Board by appointing two industry veterans. See our latest analysis for Aptera Motors. Aptera’s latest flurry of leadership changes, index inclusion, and new share filings has certainly kept it in the headlines, and the stock has responded in kind. After surging over 50% in the past week,...
OM:ORX
OM:ORXPharmaceuticals

Orexo (OM:ORX) Heads Into Earnings With Ongoing Losses and Sector-Low 1.8x Price-To-Sales Ratio

Orexo (OM:ORX) remains unprofitable, with losses increasing at an average rate of 3.7% per year over the past five years. Revenue is forecast to grow by 2.5% annually, trailing behind the broader Swedish market’s 3.9% average growth. While the company’s slower growth and ongoing losses present real challenges for investors, the current Price-To-Sales Ratio of 1.8x stands out as a notable value play within the European pharmaceuticals sector. See our full analysis for Orexo. Next up, we’ll see...
XTRA:MBK
XTRA:MBKBanks

Merkur PrivatBank (XTRA:MBK) Profit Margin Tops Prior Year, Challenges Narratives on Valuation Premium

Merkur PrivatBank KgaA (XTRA:MBK) reported a net profit margin of 9.4%, edging up from 9.3% last year, with annual earnings growth of 11.8% far outpacing its five-year annualized rate of 0.9%. While earnings are projected to grow by 9.8% per year going forward, which is below the German market’s expected 16.5%, and revenue is forecast to rise at 3.1% per year compared to the 6% market average, the figures point to improving profitability with some acceleration on recent trends. Investors are...
CNSX:HBFG
CNSX:HBFGHealthcare Services

Happy Belly Food Group (CNSX:HBFG): Valuation Considerations After High-Profile Heal Wellness Expansion at Eaton Centre

Happy Belly Food Group (CNSX:HBFG) just made headlines with its new franchise agreement and lease for Heal Wellness at Toronto's Eaton Centre, one of the most visited retail locations in Canada. This step is an important milestone in the company’s national expansion strategy. See our latest analysis for Happy Belly Food Group. Momentum has been picking up for Happy Belly Food Group, with the stock’s 30-day share price return of 22.5% and a remarkable 59.4% return over the last 90 days...